Citadel Advisors’s BlackRock ESG Capital Allocation Term Trust ECAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-41,203
Closed -$553K 14873
2022
Q4
$553K Sell
41,203
-56,961
-58% -$778K ﹤0.01% 8031
2022
Q3
$1.26M Sell
98,164
-10,393
-10% -$150K ﹤0.01% 6501
2022
Q2
$1.55M Buy
108,557
+12,565
+13% +$186K ﹤0.01% 6070
2022
Q1
$1.6M Buy
+95,992
New +$1.62M ﹤0.01% 6587

Other funds holding ECAT

Citadel Advisors's ECAT Position: Q1 2023 in Review

Citadel Advisors sold out of BlackRock ESG Capital Allocation Term Trust (ECAT) in Q1 2023, closing a stake of 41,203 shares — an estimated $553K sold.

Citadel Advisors first reported a position in ECAT in Q1 2022 and held it in 4 quarters. The position peaked at $1.6M in Q1 2022. 65 funds tracked by Wall St. Rank hold ECAT as of Q1 2023.

  • Citadel Advisors reported no remaining BlackRock ESG Capital Allocation Term Trust position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 41,203 BlackRock ESG Capital Allocation Term Trust shares in Q1 2023, an estimated $553K.
  • Citadel Advisors first reported a position in BlackRock ESG Capital Allocation Term Trust in Q1 2022 and held it in 4 quarters.
  • Citadel Advisors's BlackRock ESG Capital Allocation Term Trust position peaked at $1.6M in Q1 2022.
  • 65 funds tracked by Wall St. Rank held BlackRock ESG Capital Allocation Term Trust as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.